Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Schuuring

Showing results (61-70 of 210) with videos related to

Pageof 21
Sort By:
Genes, Chromosomes & Cancer|August 3, 2005
BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3BAnneke G Bosga-Bouwer, Eugenia Haralambieva, Marije Booman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 24, 2018
KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLCMaarten Niemantsverdriet, Ed Schuuring, Arja Ter Elst, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2025
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancerPaul Hofman, Petros Christopoulos, Nicky D'Haene, et al.
Cancers|February 26, 2025
Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation Using Headroom AnalysisKelly M Castañeda, Karin M Vermeulen, Antoinette D I van Asselt, et al.
The Journal of Molecular Diagnostics : JMD|October 4, 2020
Staining Performance of ALK and ROS1 Immunohistochemistry and Influence on Interpretation in Non-Small-Cell Lung CancerCleo Keppens, Jan von der Thüsen, Patrick Pauwels, et al.
Journal of Clinical Microbiology|October 10, 2014
Clinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screeningAniek Boers, Rong Wang, Lorian Slagter-Menkema, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2009
Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentityMargit Schraders, Sabine Oeschger, Philip M Kluin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphomaMarije Booman, Jenny Douwes, Annuska M Glas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 17, 2009
Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphomaJan-Lukas Robertus, Geert Harms, Tjasso Blokzijl, et al.
Virchows Archiv : an International Journal of Pathology|August 26, 2017
Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers' surveyZandra C Deans, Hannah Williams, Elisabeth M C Dequeker, et al.
Pageof 21

Showing results (61-70 of 210) with videos related to

Sort By:
Pageof 21
Genes, Chromosomes & Cancer|August 3, 2005
BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3BAnneke G Bosga-Bouwer, Eugenia Haralambieva, Marije Booman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 24, 2018
KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLCMaarten Niemantsverdriet, Ed Schuuring, Arja Ter Elst, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2025
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancerPaul Hofman, Petros Christopoulos, Nicky D'Haene, et al.
Cancers|February 26, 2025
Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation Using Headroom AnalysisKelly M Castañeda, Karin M Vermeulen, Antoinette D I van Asselt, et al.
The Journal of Molecular Diagnostics : JMD|October 4, 2020
Staining Performance of ALK and ROS1 Immunohistochemistry and Influence on Interpretation in Non-Small-Cell Lung CancerCleo Keppens, Jan von der Thüsen, Patrick Pauwels, et al.
Journal of Clinical Microbiology|October 10, 2014
Clinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screeningAniek Boers, Rong Wang, Lorian Slagter-Menkema, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2009
Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentityMargit Schraders, Sabine Oeschger, Philip M Kluin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphomaMarije Booman, Jenny Douwes, Annuska M Glas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 17, 2009
Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphomaJan-Lukas Robertus, Geert Harms, Tjasso Blokzijl, et al.
Virchows Archiv : an International Journal of Pathology|August 26, 2017
Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers' surveyZandra C Deans, Hannah Williams, Elisabeth M C Dequeker, et al.
Pageof 21